Evidence map›Paper›PMID 24362839›Full record

ArticleNucleic acids research2014

Interaction-based discovery of functionally important genes in cancers.

Dario Ghersi, Mona Singh

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Computational Approaches to Prioritize Cancer Driver Missense Mutations.International journal of molecular sciences · 2018
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dario GhersiLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08544, USA and Department of Computer Science, Princeton University, Princeton, NJ 08544, USA.
Mona Singh
Princeton University · US

Funding

Spatial Patterning During DevelopmentP50GM071508 · NIGMS · PRINCETON UNIVERSITY · PI POWELL, SUSAN M · 2004 to 2013
$30.6M
Predicting and analyzing variation in cellular interactomesR01GM076275 · NIGMS · PRINCETON UNIVERSITY · PI SINGH, MONA · 2006 to 2022
$4.0M
NIGMS NIH HHS GM076275NIGMS NIH HHS P50 GM071508NIGMS NIH HHS R01 GM076275
6 · The paper itself

Abstract

A major challenge in cancer genomics is uncovering genes with an active role in tumorigenesis from a potentially large pool of mutated genes across patient samples. Here we focus on the interactions that proteins make with nucleic acids, small molecules, ions and peptides, and show that residues within proteins that are involved in these interactions are more frequently affected by mutations observed in large-scale cancer genomic data than are other residues. We leverage this observation to predict genes that play a functionally important role in cancers by introducing a computational pipeline (http://canbind.princeton.edu) for mapping large-scale cancer exome data across patients onto protein structures, and automatically extracting proteins with an enriched number of mutations affecting their nucleic acid, small molecule, ion or peptide binding sites. Using this computational approach, we show that many previously known genes implicated in cancers are enriched in mutations within the binding sites of their encoded proteins. By focusing on functionally relevant portions of proteins--specifically those known to be involved in molecular interactions--our approach is particularly well suited to detect infrequent mutations that may nonetheless be important in cancer, and should aid in expanding our functional understanding of the genomic landscape of cancer.

Indexed as

Genes, Neoplasmbeta-Transducin Repeat-Containing ProteinsBinding SitesDEAD-box RNA HelicasesDNA-Binding ProteinsHumansMutation, MissenseNeoplasmsPolymorphism, GeneticProteinsProto-Oncogene Proteins c-aktRibonuclease IIISoftwareTranscription FactorsUbiquitin-Protein LigasesAKT3 protein, humanbeta-Transducin Repeat-Containing ProteinsDEAD-box RNA HelicasesDICER1 protein, humanDNA-Binding ProteinsFBXW11 protein, humanMBD1 protein, humanProteinsProto-Oncogene Proteins c-aktRibonuclease IIITranscription FactorsUbiquitin-Protein Ligases

Identifiers

PMID24362839
PMCPMC3919581
OpenAlexW2064990035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.